Study title: "Evaluation de l'acceptabilité et de la tolérance de la cloxacilline poudre pédiatrique pour suspension buvable 250 mg, en sachets, dans les angines streptococciques et infections cutanées de l'enfant"
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Bacterial Infections and Mycoses [C01] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CLOXACILLIN | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: 01-ORB-02 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |